India Pharma Outlook Team | Thursday, 09 October 2025
Enzene Biosciences Ltd., a premier Continuously Innovative Development and Manufacturing Organization (CIDMO) for biologics, has entered the immersive learning space by partnering with Virtuosi.
Virtuosi have been developed by Quality Executive Partners, Inc., (QxP) and are the world’s first immersive learning platform for pharmaceutical manufacturing with IACET accreditation.
The partnership allows Enzene to be the first company from India to integrate Virtuosi into its workforce development programs—a significant step towards developing a totally skilled, globally competitive pharmaceutical workforce.
This partnership is an important hallmark for the industry, which bridges the gap between technological innovation and higher education to support India’s position as a leader in global biologics manufacturing.
Also Read: How to Bridge the Healthcare Gap in Emerging Markets with MedTech
Crystal Mersh, Chief Executive Officer and Founder of Quality Executive Partners, said, “As the first global company to implement Virtuosi in India, Enzene signals a new era of manufacturing excellence—showcasing that India’s CIDMO sector is not only scaling capacity, but also investing in the people and knowledge needed to sustain excellence. Enzene is leading the way.”
Through the Virtuosi immersive learning platform, Enzene will promote a continuum of scalable, engaging, accredited training for its teams that encompasses virtual reality (VR), digital simulation, and technical curricula. Training will focus on aseptic process operations, quality assurance, data integrity, and regulatory compliance—all important competencies in the modern drug manufacturing arena.
Enzene Biosciences believes in building a culture of continuous learning and operational excellence. By investing in the Virtuosi immersive learning platform, Enzene is enhancing its capabilities and supporting a growing reputation for India as a global destination for advanced biologics manufacturing.
The Enzene–Virtuosi partnership sets a new benchmark for how innovation, technology, and education can converge to shape the future of the pharmaceutical industry.
